Galunisertib Combined With Capecitabine in Advanced CRC With PM
Clinical trial NCT05700656 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05700656
- Sponsor
- The Netherlands Cancer Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2026-12-01
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.